PHARMACOGENETICS OF IRINOTECAN: MINIMISING TOXICITIES AND MAXIMISING CLINICAL RESPONSE

B. Kularatne, A. Marinaki, J. Spicer, A. Loganayagam, P. Ross

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)I35 - I35
JournalAnnals of Oncology
Volume21
Publication statusPublished - 2010

Cite this